We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · February 15, 2021

Sotagliflozin Plus Insulin in T1D

Diabetes Technology & Therapeutics


Additional Info

Diabetes Technology & Therapeutics
Improvement in Patient-Reported Outcomes in Adults with Type 1 Diabetes Treated with Sotagliflozin Plus Insulin Versus Insulin Alone
Diabetes Technol. Ther. 2021 Jan 01;23(1)70-77, T Danne, VN Joish, M Afonso, P Banks, S Sawhney, P Lapuerta, MJ Davies, JB Buse, D Lin, M Reaney, S Guillonneau, FJ Snoek, TS Bailey, WH Polonsky

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading